A gene expression panel identifies origin site of neuroendocrine tumors
Differing spectra of CTNNB1 and PTEN mutations in gynecologic tumors

See page 128
Low-grade endometrial endometrioid carcinoma (EEC) and ovarian endometrioid carcinomas (OEC) have similar morphologic characteristics and shared molecular derangements. McConechy et al examined cohorts of these two tumors and found that PTEN mutations are more prevalent in EEC whereas CTNNB1 mutations are more prevalent in OEC. The prevalence of PTEN, however, was similar in both tumors. ARID1A, KRAS, PP2R1A, and TP53 were relatively common in both tumors, with similar distributions. These differences suggest dissimilarities in the microenvironments in which EEC and OEC arise, thus suggesting insights into pathogenesis, despite the equivalent histologic findings. In addition, these differences may eventually lead to divergent rational therapeutic approaches in upcoming clinical trials.
Laboratory Investigation
A quantitative fluorescence-based method to assess Ki-67 score in mammary carcinoma
See page 98
Previous studies have suggested an association of proliferation indexes derived using Ki-67 markers with response to treatment for breast cancer. However, there is no consensus on a method for assessing Ki-67. Using a well-characterized immunofluorescence platform, Brown and colleagues examined a cohort of 105 pretreatment core-needle biopsy specimens for Ki-67 reactivity. The number of fields of view examined ranged from 5 to 115, with a mean of 30. The results were reported as percentage of positive tumor nuclei and automated quantitative analysis (AQUA) score. The latter uses anti-cytokeratin antibodies to identify tumor cells and 4′6-diamidino-2-phenylindol to identify the nuclei within tumor cells. The Ki-67 nuclear intensity was determined within tumor nuclei and divided by total doi:10.1038/modpathol.2013.221 nature.com/pathology tumor nuclei area to obtain the AQUA score. Full multivariate analysis showed that both the mean and maximum Ki-67 AQUA scores in a particular field of view were significant independent predictors of pathologic complete response to neoadjuvant chemotherapy, as was percentage of positive tumor nuclei. This rigorous and objective assessment of Ki-67 expression confirms that it is an important variable for predicting therapeutic outcome.
Loss of inflammatory pathway expression correlates with advanced HCC stage and poor differentiation
See page 52
There are intracellular protein heterocomplexes called inflammasomes that serve as staging areas for the maturation and secretion of the key proinflammatory cytokine interleukins, IL-1β and IL-18. NLRP3 is perhaps the best characterized inflammasome and serves to incite an inflammatory response upon detection of various insults to the host and thus generally plays a protective role for the host. Wei et al demonstrate loss of this inflammasome in hepatocellular carcinoma (HCC) relative to adjacent normal liver. They assessed this by both immunohistochemistry and quantitative reverse transcription-PCR for multiple components of this complex and IL-1β. Reduced expression was also seen in cirrhosis, and in HCC was correlated with both advanced tumor stage and poor differentiation. This suggests a role for loss of this inflammasome in HCC tumor progression, perhaps by allowing the tumor to manipulate its local microenvironment so as to evade attack by the host immune system.
Similar mutations in two bone tumors
Behjati et al identified highly prevalent and recurrent hotspot mutations in histone H3.3 genes (H3HFA and H3HFB) in chondroblastoma (CB) and giant-cell tumor of bone (GCTB). Slightly different mutations in two very similar genes in two different rare bone tumors suggests variant expressions of a single entity. However, clinically and histologically these two tumors are different. Both are locally aggressive, but CB presents at a young age near the epiphysis whereas GCTB occurs after closure of the growth plate. IDH mutations, which are common in chondrosarcoma, are presumed to affect DNA and histone methylation. This study reveals that CB and GCTB show alterations in epigenetic genes. Whereas recurrent chromosomal changes are absent in CB, GCTB features telomeric associations. Clinical inhibition of RANK ligand in GCTB produced by the mononuclear cells prevents recruitment of osteoclasts expressing the receptor, resulting in sclerotic fibrous tissue. The connection between H3HFB mutation and RANK ligand expression requires further elucidation.
An integrin pathway important for fibrosis
Fibrosis, a critical end point in several organ diseases, is usually recalcitrant to treatments other than organ transplantation. Secretion of transforming growth factor-β is known to be a critical mediator of fibrosis in multiple organs, but its molecular activators are less well understood. Henderson et al demonstrated that a Pdgfrb-Cre system controlled by the Pdgfrb promoter inactivates α v integrin in myofibroblasts of several mouse organs. Loss of α v integrin was highly protective against fibrosis induced by bleomycin. This was confirmed using a small-molecule inhibitor of α v -integrin function. The α v -integrin subunits combine with sundry β-integrin subunits in myofibroblasts resident in various organs. In vivo disruption of these α v -integrin subunits and certain αβ-integrin dimers can provide broad protection against fibrosis and might have therapeutic efficacy. 
